|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
2006-2-21
|
|
pubmed:abstractText |
The effect of beta-blockade on the cardiac natriuretic peptides is poorly understood but could contribute to their beneficial treatment effect and may be relevant to clinical use of plasma brain natriuretic peptide (BNP)/N-terminal pro brain natriuretic peptide (NTproBNP) measurements in risk stratification and in titration of anti-heart failure therapy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
1524-4539
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
21
|
|
pubmed:volume |
113
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
977-85
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:16476851-Adrenergic beta-Antagonists,
pubmed-meshheading:16476851-Aged,
pubmed-meshheading:16476851-Atrial Natriuretic Factor,
pubmed-meshheading:16476851-Cyclic GMP,
pubmed-meshheading:16476851-Heart Failure,
pubmed-meshheading:16476851-Humans,
pubmed-meshheading:16476851-Male,
pubmed-meshheading:16476851-Metoprolol,
pubmed-meshheading:16476851-Middle Aged,
pubmed-meshheading:16476851-Natriuretic Peptide, Brain,
pubmed-meshheading:16476851-Peptide Fragments
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Introduction of metoprolol increases plasma B-type cardiac natriuretic peptides in mild, stable heart failure.
|
|
pubmed:affiliation |
The Cardioendocrine Research Group, Christchurch School of Medicine and Health Sciences, Christchurch, New Zealand. mark.davis@chmeds.ac.nz
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
